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Abstract
Background. Both acute stress ulcer and liver failure are well-known complications of hepatic resection. This case study
documents how an episode of postoperative gastrointestinal haemorrhage can provoke transient hepatic failure. Case outline.
A 66-year-old woman with no previous history of reflux oesophagitis or peptic ulcer disease underwent a right liver resection
for a solitary metastasis. On the fifth postoperative day, with a small premonitory haematemesis, she was started on
omeprazole intravenously. She subsequently required blood transfusion and endoscopy; a bleeding acute gastric ulcer was
injected with adrenalin. She then progressed to acute liver failure with associated hepatic encephalopathy but made a full
recovery. Discussion. Adverse effects of prophylactic H2 receptor antagonists have included liver failure and hepatitis, and
animal studies have shown inhibition of liver regeneration after hepatectomy. Proton pump inhibitors (PPIs) have an
acceptable profile of adverse events and their effect on liver regeneration appears to be favourable. Given the serious potential
for liver failure in the event of significant bleeding, a PPI is advocated for routine prophylaxis against acute stress ulceration
in all major liver resections.
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Introduction
In the last decade, major hepatectomy has become a
safer operation with a decrease in both morbidity and
mortality rates. Nevertheless a number of reports have
demonstrated the potential for both acute stress
ulcer and hepatic failure. This case report documents
how a particular complication, acute gastrointestinal
haemorrhage, can affect the subsequent postoperative
course of a patient already compromised by the initial
operation.
Case report
A 66-year-old woman presented for a right hepatec-
tomy for a metastatic solitary liver lesion from a
retroperitoneal malignant fibrous histiocytoma that
had been resected in April 2001. A CT scan of the
abdomen in August 2002 showed a new 6-cm hypo-
dense lesion within the right lobe of the liver, involving
segments V and VIII. The past history was unremark-
able except for hypertension, and specifically there
was no history of reflux oesophagitis or peptic ulcer
disease.
A right hepatectomy was performed and 4 units of
blood were given intra-operatively. On day 5, she had
a small haematemesis, and a PPI (omeprazole 40 mg
daily) was commenced intravenously. She had further
episodes of haematemesis with a fall in haemoglobin
to 0.99 mmol/L (6.4 g/dl) from the initial post-
operative level of 1.86 mmol/L (12 g/dl), but she
remained haemodynamically stable. Three units of
blood were transfused. Endoscopy showed a 0.75-cm
acute gastric ulcer with active bleeding. The ulcer was
injected with 0.5 ml of adrenalin (1 : 10 000). On day
7, the patient developed melaena, her conscious state
deteriorated and a “liver flap” became apparent. Liver
function tests showed marked abnormalities and a
diagnosis of hepatic encephalopathy secondary to liver
failure was proposed. She became hypoxic and was
transferred to the Intensive Care Unit for intubation
and supportive measures. She was extubated after
2 days with her liver function gradually improving.
The patient was discharged home on the 18th post-
operative day.
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Discussion
Upper gastrointestinal bleeding from acute stress
ulcers can be encountered in various critical conditions,
including major operations such as hepatic resection.
Early reports described this complication quite fre-
quently [1–3], but more recent articles have not always
commented on this complication nor recorded its
frequency. This apparent reduction may be due to
prophylactic treatment, but such prophylaxis is not
specified in the more recent series [4].
A prospective, randomised study showed that
cimetidine was effective in preventing gastrointestinal
bleeding in patients undergoing partial hepatectomy
[5]. However, concern that cimetidine may induce
liver failure or hepatitis was expressed. Furthermore,
animal studies have shown that cimetidine therapy
inhibits liver regeneration after a two-thirds hepatec-
tomy [6].
In a clinical study by Yamashita and co-workers [7],
pre-operative administration of methyl-prednisolone
elevated anti-inflammatory cytokine interleukin (IL)-
10 levels and suppressed inflammatory cytokines IL-6
and C-reactive protein in patients undergoing hepatic
resection, which confirmed the ability to suppress
surgical stress in patients undergoing hepatic resection.
The practical relevance of this finding is unclear.
Animal experiments have shown omeprazole to
stimulate liver regeneration after partial hepatectomy
and that this often may be mediated by gastrin [8].
However, it must also be noted that on rare occasions
both fulminant liver failure and hepatitis have also been
reported with the use of this agent [9–11].
A review of the literature has not found any current
recommendations for the use of a PPI as routine
prophylaxis in liver surgery and it has not been an
element of this unit’s protocol for hepatectomy.
Initiation of PPI therapy on day 5 as in this case must
be considered therapeutic rather than prophylactic
and further bleeding before ulcer healing was not
surprising. The overall incidence of adverse events
with omeprazole is low and no drug-related adverse
event has been found in patients with severe liver
failure [12]. It is proposed that the ensuing liver failure
in this reported case reflected insufficient residual
functional liver mass to handle blood degradation
products from the alimentary tract rather than an
adverse event related to a specific PPI. The immediate
onset of liver dysfunction with rapid recovery in spite
of continued PPI therapy supports this concept.
The optimal regime for prevention of stress ulcera-
tion is debatable [13–16], but we propose that, given
the serious potential for liver failure in the event
of significant gastrointestinal bleeding, a PPI be used
routinely as prophylaxis against acute stress ulceration
in all major liver resections. Although there are no data
to determine the duration of prophylaxis, it is sugges-
ted that it continue for the period of hospitalisation.
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